High Pointe Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.05M | Sell |
26,519
-3,770
| -12% | -$291K | 1.47% | 29 |
|
|
2021
Q4 | $2.68M | Buy |
30,289
+7,479
| +33% | +$661K | 1.78% | 15 |
|
|
2021
Q3 | $1.76M | Hold |
22,810
| – | – | 1.39% | 33 |
|
|
2021
Q2 | $1.9M | Sell |
22,810
-430
| -2% | -$35.9K | 1.5% | 29 |
|
|
2021
Q1 | $1.76M | Buy |
23,240
+340
| +1% | +$25.7K | 1.54% | 32 |
|
|
2020
Q4 | $2.01M | Buy |
+22,900
| New | +$2.01M | 1.9% | 16 |
|
|
2018
Q4 | – | Sell |
-3,950
| Closed | -$383K | – | 85 |
|
|
2018
Q3 | $383K | Sell |
3,950
-1,780
| -31% | -$173K | 0.52% | 63 |
|
|
2018
Q2 | $540K | Sell |
5,730
-60
| -1% | -$5.65K | 0.77% | 50 |
|
|
2018
Q1 | $469K | Buy |
5,790
+240
| +4% | +$19.4K | 0.64% | 60 |
|
|
2017
Q4 | $495K | Hold |
5,550
| – | – | 0.68% | 54 |
|
|
2017
Q3 | $517K | Buy |
5,550
+110
| +2% | +$10.2K | 0.76% | 52 |
|
|
2017
Q2 | $494K | Buy |
5,440
+1,280
| +31% | +$116K | 0.77% | 52 |
|
|
2017
Q1 | $365K | Hold |
4,160
| – | – | 0.58% | 56 |
|
|
2016
Q4 | $345K | Hold |
4,160
| – | – | 0.57% | 53 |
|
|
2016
Q3 | $385K | Buy |
+4,160
| New | +$385K | 0.68% | 50 |
|